Study demonstrates that transplanting gut microbiota from young donors — or simply supplementing the amino acid glutamic acid — can rejuvenate deteriorated oocyte quality associated with advancing reproductive age, opening promising avenues for female fertility treatment.

Researchers have identified a direct link between the composition of the gut microbiome and the quality of female egg cells, finding that a decline in a specific bacterial metabolite — glutamic acid — contributes significantly to age-related deterioration in oocyte health. The findings, published as an open-access study, suggest that restoring glutamic acid levels, either through microbiome intervention or direct dietary supplementation, can meaningfully reverse this decline.

The gut microbiome is increasingly recognised as a central regulator of systemic health. As it ages, its microbial composition shifts in ways that reduce the production of beneficial metabolites while simultaneously increasing inflammatory signals that damage tissues throughout the body. This study demonstrates for the first time that such changes have a measurable impact on reproductive health — specifically, on the quality of oocytes produced by ageing ovaries.

Using aged female mice as subjects, the research team conducted fecal microbiota transplantation (FMT) — a procedure in which gut microbiota from young donors is introduced into older recipients — and observed a significant restoration in oocyte quality. Specifically, the transplantation improved ovulation rates and oocyte maturation, while reducing the incidence of abnormalities including cytoplasmic fragmentation and spindle or chromosomal defects, all of which are associated with failed fertilisation and early embryo loss.

Through an integrated analysis combining metagenomic profiling of intestinal microbiota, metabolomic mapping of ovarian tissue, and micro-transcriptomic examination of individual oocytes, the team traced the restorative mechanism to a single bacterial species: Bacteroides caecimuris. This microorganism plays a key role in modulating glutamic acid levels in the gut, and its relative abundance declines with age. The resulting fall in glutamic acid was found to weaken mitochondrial function within oocytes — a critical factor, given that mitochondria provide the energy required for successful fertilisation and early embryonic development.

Critically, the study found that direct in vivo supplementation of glutamic acid produced equivalent improvements in oocyte quality, without the need for microbiome transplantation. The effect was also confirmed to be conserved across species, suggesting the findings are likely applicable beyond the mouse model. This positions glutamic acid supplementation as a potentially accessible and straightforward clinical intervention for age-related decline in female fertility.

The research contributes to a growing body of work exploring the gut microbiome as a modifiable target for healthy ageing. Earlier approaches have demonstrated that flagellin immunisation — which prompts the immune system to suppress problematic bacterial species that proliferate with age — and FMT from young donors can both reset microbiome composition toward a more youthful state. The current findings advance this field by identifying a specific metabolic pathway through which the gut microbiome influences reproductive ageing, and by demonstrating that targeted supplementation may achieve comparable results to wholesale microbiome intervention.

The implications extend beyond fertility. Mitochondrial dysfunction is a widely recognised driver of cellular ageing across tissues, and the identification of glutamic acid as a gut-derived regulator of mitochondrial health in oocytes may have broader relevance to ovarian reserve, hormonal function, and overall reproductive longevity. Researchers note that oocyte quality is among the most sensitive indicators of female biological age, making it a valuable window into systemic ageing processes.

The study opens several avenues for further research, including the potential development of targeted probiotic formulations designed to restore Bacteroides caecimuris populations, the clinical evaluation of glutamic acid supplementation protocols in women of advanced reproductive age, and the creation of tailored synthetic microbiomes engineered to maintain optimal metabolite profiles. The authors conclude that their findings highlight the importance of the gut microbiome in oocyte ageing and provide a foundation for novel strategies to address age-related fertility decline.

Notes to Editors

The study “Gut microbiota-modulated glutamic acid rejuvenates the quality of oocytes deteriorated by advanced reproductive age” is available as an open-access publication. The research was conducted using aged female mouse models and employed fecal microbiota transplantation alongside multi-omic analytical methods including metagenomics, untargeted and targeted metabolomics, and micro-transcriptomics.

Oocytes are female reproductive cells (eggs). Oocyte quality refers to the capacity of an egg to be successfully fertilised and to support healthy embryonic development. Age-related decline in oocyte quality is a leading cause of reduced fertility in women over 35.

Glutamic acid is a non-essential amino acid involved in cellular energy metabolism and nitrogen transport. It is found in many protein-rich foods and is also produced endogenously and by gut microbiota.

Source: fightaging.org — https://www.fightaging.org/archives/2026/06/gut-microbiome-derived-or-supplemented-glutamic-acid-improves-the-quality-of-aged-oocytes/